GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Tax Expense

Yidu Tech (HKSE:02158) Tax Expense : HK$-0.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Tax Expense?

Yidu Tech's tax expense for the months ended in Mar. 2024 was HK$-0.1 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2024 was HK$-0.2 Mil.


Yidu Tech Tax Expense Historical Data

The historical data trend for Yidu Tech's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech Tax Expense Chart

Yidu Tech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Expense
Get a 7-Day Free Trial 0.59 1.69 -0.60 3.90 0.05

Yidu Tech Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 1.81 0.18 -0.13 -0.04

Yidu Tech Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yidu Tech  (HKSE:02158) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Yidu Tech Tax Expense Related Terms

Thank you for viewing the detailed overview of Yidu Tech's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Yidu Tech Business Description

Traded in Other Exchanges
Address
No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 40% of its revenue in 2024 and it is its core business.
Executives
Gong Yingying 2202 Interest of your spouse
Xu Jiming 2101 Beneficial owner
Brunei Investment Agency 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
Sweet Panda Limited 2101 Beneficial owner

Yidu Tech Headlines

No Headlines